Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ohio Patient's Choice (OPC) is a vertically integrated medical cannabis company based in Ohio, specializing in the cultivation, processing, and retail of medical-grade marijuana. The company operates a state-of-the-art Level 1 cultivation facility in Huron, Ohio, where it produces a variety of cannabis strains and derivative products. OPC was established to serve patients under Ohio's Medical Marijuana Control Program, focusing on high standards of quality and safety. In May 2021, the company was acquired by Verano Holdings, a leading multi-state cannabis operator, as part of Verano's expansion into the Ohio market. Its retail dispensaries have since been integrated into the Zen Leaf brand, while its production arm continues to supply the state's patient population. The company's product line includes flower, vape cartridges, concentrates, and infused edibles designed to alleviate symptoms of chronic pain, neurological disorders, and other qualifying conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ohio Patient’s Choice.